Consolidated Statements of Cash Flows (USD $) In Thousands, unless otherwise specified	12 Months Ended
	Dec. 31, 2013		Dec. 31, 2012		Dec. 31, 2011
Cash used in operating activities
Net (loss) income and comprehensive (loss) income	$ (24,871)		$ 45,698		$ (30,416)
Adjustments to reconcile net (loss) income to net cash used in operating activities
Depreciation	964		1,254		1,433
Stock-based compensation and restricted stock based compensation	599		5,751		2,973
Unrealized foreign exchange losses	254		166		131
Deferred income taxes	730		1,779		3,661
Impairment of long-lived assets	64		1,056
Recovery on assets held for sale	(153)
Gain on sale of discontinued operations (Note 12)	(1,053)	[1]	(101,412)	[2]
Gain on sale of long-lived assets	(221)		(45)		(269)
Fair value change in contingent consideration (Notes 10, 13)	1,273
Changes in non-cash operating assets and liabilities
Accounts receivable	2,306		6,777		1,029
Inventories			361		2,118
Prepaid and other assets	(421)		888		2,139
Accounts payable	(2,916)		310		236
Income taxes receivable / payable	478		(265)		(937)
Accrued liabilities	(1,047)		(5,852)		1,324
Accrued restructuring	(1,803)		1,954
Cash used in operating activities	(25,817)		(41,580)		(16,578)
Cash provided by investing activities
Net proceeds from sale of long-lived assets	102		767		19
Net proceeds from sale of discontinued operations (Note 12)	8,486		101,461
Purchase of property, plant and equipment	(223)		(892)		(3,317)
Proceeds from mortgage receivable			5,874		2,004
Proceeds from contingent consideration (Notes 10, 13)	34,599		28,845		30,641
Other	66
Cash provided by investing activities	43,030		136,055		29,347
Cash (used in) provided by financing activities
Common shares repurchased, including fees	(14,079)		(13,096)		(18,839)
Cash distribution paid to common shareholders (Note 8 (b))	(200,000)
Issuance of common shares	8,317		20,417		2,182
Cash used in financing activities	(205,762)		7,321		(16,657)
Effect of exchange rate changes on cash and cash equivalents	(314)		(9)		7
Net (decrease) increase in cash and cash equivalents	(188,863)		101,787		(3,881)
Cash and cash equivalents, beginning of year	307,384		205,597		209,478
Cash and cash equivalents, end of year	118,521		307,384		205,597
Supplementary cash flow information:
Income taxes paid			$ 392		$ 994

[1] During the year ended December 3 1, 2013, the net gain on sale of discontinued operations of $1.1 million represents total proceeds of $1.2 million related to the sale of our PPDS Technology to Mati in April 2013; net of the $0.2 million carrying value of certain equipment sold, which was previously classified as held for sale, and a negligible amount of transaction fees.

[2] During the year ended December 31, 2012, the net gain of $101.4 million relates to the gain on the sale of our Visudyne business to Valeant in September 2012.